vs
EyePoint, Inc.（EYPT）与沃特世（WAT）财务数据对比。点击上方公司名可切换其他公司
沃特世的季度营收约是EyePoint, Inc.的1506.2倍（$932.4M vs $619.0K）。沃特世净利率更高（24.2% vs -10922.3%，领先10946.4%）。沃特世同比增速更快（6.8% vs -94.7%）。过去两年沃特世的营收复合增速更高（21.0% vs -77.0%）
EyePoint制药公司总部位于马萨诸塞州沃特敦，是一家专注于将微机电系统（MEMS）与纳米技术应用于给药领域的专业医药企业，依托前沿交叉技术开发创新给药方案，聚焦眼科等领域的药物递送技术创新与产品开发。
沃特世是总部位于美国马萨诸塞州米尔福德的企业，面向生命科学、材料、食品等行业，提供色谱、质谱、实验室信息学、流变测量领域所用的分析仪器及配套软件，为各领域的检测、研发等工作提供可靠技术支持。
EYPT vs WAT — 直观对比
营收规模更大
WAT
是对方的1506.2倍
$619.0K
营收增速更快
WAT
高出101.5%
-94.7%
净利率更高
WAT
高出10946.4%
-10922.3%
两年增速更快
WAT
近两年复合增速
-77.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $619.0K | $932.4M |
| 净利润 | $-67.6M | $225.2M |
| 毛利率 | — | 61.1% |
| 营业利润率 | -11364.3% | 29.0% |
| 净利率 | -10922.3% | 24.2% |
| 营收同比 | -94.7% | 6.8% |
| 净利润同比 | -63.3% | -2.7% |
| 每股收益（稀释后） | $-0.82 | $3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EYPTWAT
| Q4 25 | $619.0K | $932.4M | ||
| Q3 25 | $966.0K | $799.9M | ||
| Q2 25 | $5.3M | $771.3M | ||
| Q1 25 | $24.5M | $661.7M | ||
| Q4 24 | $11.6M | $872.7M | ||
| Q3 24 | $10.5M | $740.3M | ||
| Q2 24 | $9.5M | $708.5M | ||
| Q1 24 | $11.7M | $636.8M |
净利润EYPTWAT
| Q4 25 | $-67.6M | $225.2M | ||
| Q3 25 | $-59.7M | $148.9M | ||
| Q2 25 | $-59.4M | $147.1M | ||
| Q1 25 | $-45.2M | $121.4M | ||
| Q4 24 | $-41.4M | $231.4M | ||
| Q3 24 | $-29.4M | $161.5M | ||
| Q2 24 | $-30.8M | $142.7M | ||
| Q1 24 | $-29.3M | $102.2M |
毛利率EYPTWAT
| Q4 25 | — | 61.1% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 58.2% | ||
| Q4 24 | — | 60.1% | ||
| Q3 24 | 93.0% | 59.3% | ||
| Q2 24 | 85.2% | 59.3% | ||
| Q1 24 | 93.5% | 58.9% |
营业利润率EYPTWAT
| Q4 25 | -11364.3% | 29.0% | ||
| Q3 25 | -6420.8% | 24.0% | ||
| Q2 25 | -1166.8% | 24.4% | ||
| Q1 25 | -199.7% | 22.9% | ||
| Q4 24 | -390.4% | 33.5% | ||
| Q3 24 | -311.2% | 28.5% | ||
| Q2 24 | -364.5% | 26.7% | ||
| Q1 24 | -285.2% | 21.0% |
净利率EYPTWAT
| Q4 25 | -10922.3% | 24.2% | ||
| Q3 25 | -6183.4% | 18.6% | ||
| Q2 25 | -1114.3% | 19.1% | ||
| Q1 25 | -184.8% | 18.3% | ||
| Q4 24 | -357.3% | 26.5% | ||
| Q3 24 | -279.0% | 21.8% | ||
| Q2 24 | -325.3% | 20.1% | ||
| Q1 24 | -250.6% | 16.0% |
每股收益（稀释后）EYPTWAT
| Q4 25 | $-0.82 | $3.76 | ||
| Q3 25 | $-0.85 | $2.50 | ||
| Q2 25 | $-0.85 | $2.47 | ||
| Q1 25 | $-0.65 | $2.03 | ||
| Q4 24 | $-0.65 | $3.88 | ||
| Q3 24 | $-0.54 | $2.71 | ||
| Q2 24 | $-0.58 | $2.40 | ||
| Q1 24 | $-0.55 | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.1M | $587.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $306.1M | $2.6B |
| 总资产 | $364.0M | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.55× |
8季度趋势，按日历期对齐
现金及短期投资EYPTWAT
| Q4 25 | $306.1M | $587.8M | ||
| Q3 25 | $204.0M | $459.1M | ||
| Q2 25 | $255.7M | $367.2M | ||
| Q1 25 | $318.2M | $382.9M | ||
| Q4 24 | $370.9M | $325.4M | ||
| Q3 24 | $253.8M | $331.5M | ||
| Q2 24 | $280.2M | $327.4M | ||
| Q1 24 | $299.3M | $338.2M |
总债务EYPTWAT
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EYPTWAT
| Q4 25 | $306.1M | $2.6B | ||
| Q3 25 | $200.2M | $2.3B | ||
| Q2 25 | $246.0M | $2.2B | ||
| Q1 25 | $298.4M | $2.0B | ||
| Q4 24 | $336.5M | $1.8B | ||
| Q3 24 | $218.7M | $1.6B | ||
| Q2 24 | $228.3M | $1.4B | ||
| Q1 24 | $249.9M | $1.3B |
总资产EYPTWAT
| Q4 25 | $364.0M | $5.1B | ||
| Q3 25 | $251.7M | $4.9B | ||
| Q2 25 | $301.1M | $4.7B | ||
| Q1 25 | $362.6M | $4.6B | ||
| Q4 24 | $418.5M | $4.6B | ||
| Q3 24 | $300.9M | $4.5B | ||
| Q2 24 | $324.2M | $4.4B | ||
| Q1 24 | $329.2M | $4.5B |
负债/权益比EYPTWAT
| Q4 25 | — | 0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | $164.6M |
| 自由现金流经营现金流 - 资本支出 | $-66.0M | — |
| 自由现金流率自由现金流/营收 | -10667.7% | — |
| 资本支出强度资本支出/营收 | 159.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.73× |
| 过去12个月自由现金流最近4个季度 | $-243.4M | — |
8季度趋势，按日历期对齐
经营现金流EYPTWAT
| Q4 25 | $-65.0M | $164.6M | ||
| Q3 25 | $-59.4M | $187.3M | ||
| Q2 25 | $-62.6M | $41.1M | ||
| Q1 25 | $-53.1M | $259.6M | ||
| Q4 24 | $-35.8M | $240.1M | ||
| Q3 24 | $-39.0M | $204.6M | ||
| Q2 24 | $-20.2M | $54.5M | ||
| Q1 24 | $-31.2M | $262.9M |
自由现金流EYPTWAT
| Q4 25 | $-66.0M | — | ||
| Q3 25 | $-60.2M | — | ||
| Q2 25 | $-63.8M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $-36.2M | — | ||
| Q3 24 | $-40.6M | — | ||
| Q2 24 | $-21.1M | — | ||
| Q1 24 | $-32.4M | — |
自由现金流率EYPTWAT
| Q4 25 | -10667.7% | — | ||
| Q3 25 | -6226.9% | — | ||
| Q2 25 | -1196.5% | — | ||
| Q1 25 | -218.4% | — | ||
| Q4 24 | -312.7% | — | ||
| Q3 24 | -385.8% | — | ||
| Q2 24 | -222.4% | — | ||
| Q1 24 | -277.0% | — |
资本支出强度EYPTWAT
| Q4 25 | 159.3% | — | ||
| Q3 25 | 82.6% | — | ||
| Q2 25 | 22.9% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 9.5% | — | ||
| Q1 24 | 10.2% | — |
现金转化率EYPTWAT
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 2.14× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 2.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
